Vibonate Injection
Marketer
Vibcare Pharma Pvt Ltd
Salt Composition
Artesunate (60mg)
Overview Vibonate Injection
Malaria is treated with Vibonate Injection, an antiparasitic drug administered intravenously by healthcare providers only. This medication is unsuitable for malaria prevention or severe cases involving brain, lung, or kidney complications. Parenteral administration is reserved for situations where oral medication is infeasible. Common side effects include headache, dizziness, fatigue, and anorexia; injection site reactions such as pain, swelling, or erythema may also occur. Persistent side effects warrant medical consultation. Post-treatment, weekly blood tests for four weeks may be conducted to monitor parasite levels.
Primary Ingredients of Vibonate Injection
The provided text is "undefined," which lacks meaning and cannot be rephrased. Therefore, no rewritten text can be provided.
Uses of Vibonate Injection
Plasmodium infection
Major Benefits of Vibonate Injection:
Administering this medication requires a healthcare professional; self-medication is not permitted.
Common Side effects of Vibonate Injection:
- Headache
- Dizziness
- Weakness
- Loss of appetite
- Injection site reactions (pain, swelling, redness)
How to use Vibonate Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Vibonate Injection works:
Vibonate Injection is an antiparasitic drug that eradicates malaria parasites by generating intracellular free radicals, leading to parasite death.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining Vibonate Injection with alcohol is undetermined. Seek medical advice before concurrent use.
PregnancyCONSULT YOUR DOCTOR
The use of Vibonate Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Vibonate Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Administration of Vibonate Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Vibonate Injection's use in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Vibonate Injection's use in patients exhibiting hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Vibonate Injection :
Omit a dose of Vibonate Injection? Seek your physician's advice.
Facts to Know About Vibonate Injection
| Label | Value |
|---|---|
| Chemical Type | Sesquiterpene lactones |
| Developing Habits | No. |
| Treatment Category | Antimalarial Medications |
| Action Class | Artemisinin-based antimalarials |
3,018 People bought this recently